Vitrification of human immature oocytes before and after in vitro maturation: a review
- PMID: 28822010
- PMCID: PMC5699986
- DOI: 10.1007/s10815-017-1005-4
Vitrification of human immature oocytes before and after in vitro maturation: a review
Abstract
The use of immature oocytes subjected to in vitro maturation (IVM) opens interesting perspectives for fertility preservation where ovarian reserves are damaged by pathologies or therapies, as in PCO/PCOS and cancer patients. Human oocyte cryopreservation may offer some advantages compared to embryo freezing, such as fertility preservation in women at risk of losing fertility due to oncological treatment or chronic disease, egg donation and postponing childbirth. It also eliminates religious and/or other ethical, legal, and moral concerns of embryo freezing. In addition, a successful oocyte cryopreservation program could eliminate the need for donor and recipient menstrual cycle synchronization. Recent advances in vitrification technology have markedly improved the oocyte survival rate after warming, with fertilization and implantation rates comparable with those of fresh oocytes. Healthy live births can be achieved from the combination of IVM and vitrification, even if vitrification of in vivo matured oocytes is still more effective. Recently, attention is given to highlight whether vitrification procedures are more successful when performed before or after IVM, on immature GV-stage oocytes, or on in vitro matured MII-stage oocytes. In this review, we emphasize that, even if there are no differences in survival rates between oocytes vitrified prior to or post-IVM, reduced maturation rates of immature oocytes vitrified prior to IVM can be, at least in part, explained by underlying ultrastructural and biomolecular alterations.
Keywords: In vitro maturation; Oocyte; Transmission electron microscopy; Ultrastructure; Vitrification.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures





Similar articles
-
Fertility preservation with immature and in vitro matured oocytes.Semin Reprod Med. 2009 Nov;27(6):456-64. doi: 10.1055/s-0029-1241055. Epub 2009 Oct 5. Semin Reprod Med. 2009. PMID: 19806514 Review.
-
Osmotic-shock produced by vitrification solutions improves immature human oocytes in vitro maturation.Reprod Biol Endocrinol. 2016 May 11;14(1):27. doi: 10.1186/s12958-016-0161-1. Reprod Biol Endocrinol. 2016. PMID: 27170005 Free PMC article.
-
Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4. Hum Reprod. 2016. PMID: 26848188
-
Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes.J Assist Reprod Genet. 2018 Sep;35(9):1683-1689. doi: 10.1007/s10815-018-1216-3. Epub 2018 Jun 4. J Assist Reprod Genet. 2018. PMID: 29869219 Free PMC article.
-
Immature Oocyte for Fertility Preservation.Front Endocrinol (Lausanne). 2019 Jul 17;10:464. doi: 10.3389/fendo.2019.00464. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379739 Free PMC article. Review.
Cited by
-
Potential Use of Immature Oocyte to Improve Fertility Preservation Outcome: A Narrative Review.J Hum Reprod Sci. 2022 Jan-Mar;15(1):3-11. doi: 10.4103/jhrs.jhrs_112_21. Epub 2022 Mar 31. J Hum Reprod Sci. 2022. PMID: 35494192 Free PMC article. Review.
-
Effects and Mechanisms of Imperatorin on Vitrified Mouse Oocytes.Animals (Basel). 2025 Feb 25;15(5):661. doi: 10.3390/ani15050661. Animals (Basel). 2025. PMID: 40075944 Free PMC article.
-
[Causes of oocyte vitrification and its value in assisted reproductive technology].Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jul 30;39(7):766-771. doi: 10.12122/j.issn.1673-4254.2019.07.03. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31340907 Free PMC article. Chinese.
-
Impact of Ovarian Factor Mediums on the Apoptotic Gene Expression and Embryo Quality Derived From Vitrified Immature Human Oocytes.J Obstet Gynaecol India. 2023 Aug;73(4):309-315. doi: 10.1007/s13224-022-01726-8. Epub 2022 Dec 31. J Obstet Gynaecol India. 2023. PMID: 37701087 Free PMC article.
-
In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program.Radiol Oncol. 2021 Dec 22;56(1):119-128. doi: 10.2478/raon-2021-0053. Radiol Oncol. 2021. PMID: 34957736 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources